105 related articles for article (PubMed ID: 1478331)
1. Effects of fermentation on product consistency.
Lubiniecki AS; Anumula K; Callaway J; L'Italien J; Oka M; Okita B; Wasserman G; Zabriskie D; Arathoon R; Builder S
Dev Biol Stand; 1992; 76():105-15. PubMed ID: 1478331
[TBL] [Abstract][Full Text] [Related]
2. Appropriate mammalian expression systems for biopharmaceuticals.
Werner RG; Noé W; Kopp K; Schlüter M
Arzneimittelforschung; 1998 Aug; 48(8):870-80. PubMed ID: 9748718
[TBL] [Abstract][Full Text] [Related]
3. Consistency and stability of recombinant fermentations.
Wiebe ME; Builder SE
Dev Biol Stand; 1994; 83():45-54. PubMed ID: 7883099
[TBL] [Abstract][Full Text] [Related]
4. Effect of shear stress on intrinsic CHO culture state and glycosylation of recombinant tissue-type plasminogen activator protein.
Senger RS; Karim MN
Biotechnol Prog; 2003; 19(4):1199-209. PubMed ID: 12892482
[TBL] [Abstract][Full Text] [Related]
5. Process parameter shifting: Part II. Biphasic cultivation-A tool for enhancing the volumetric productivity of batch processes using Epo-Fc expressing CHO cells.
Trummer E; Fauland K; Seidinger S; Schriebl K; Lattenmayer C; Kunert R; Vorauer-Uhl K; Weik R; Borth N; Katinger H; Müller D
Biotechnol Bioeng; 2006 Aug; 94(6):1045-52. PubMed ID: 16736532
[TBL] [Abstract][Full Text] [Related]
6. Mammalian cell cultures. Part II: Genetic engineering, protein glycosylation, fermentation and process control.
Werner RG; Noé W
Arzneimittelforschung; 1993 Nov; 43(11):1242-9. PubMed ID: 8292072
[TBL] [Abstract][Full Text] [Related]
7. Enhanced sialylation of recombinant erythropoietin in genetically engineered Chinese-hamster ovary cells.
Jeong YT; Choi O; Son YD; Park SY; Kim JH
Biotechnol Appl Biochem; 2009 Apr; 52(Pt 4):283-91. PubMed ID: 18590515
[TBL] [Abstract][Full Text] [Related]
8. Effect of low culture temperature on specific productivity, transcription level, and heterogeneity of erythropoietin in Chinese hamster ovary cells.
Yoon SK; Song JY; Lee GM
Biotechnol Bioeng; 2003 May; 82(3):289-98. PubMed ID: 12599255
[TBL] [Abstract][Full Text] [Related]
9. Relationship between tissue plasminogen activator production and specific growth rate in Chinese hamster ovary cells cultured in mannose at low temperature.
Berrios J; Díaz-Barrera A; Bazán C; Altamirano C
Biotechnol Lett; 2009 Oct; 31(10):1493-7. PubMed ID: 19547928
[TBL] [Abstract][Full Text] [Related]
10. Temperature effects on product-quality-related enzymes in batch CHO cell cultures producing recombinant tPA.
Clark KJ; Chaplin FW; Harcum SW
Biotechnol Prog; 2004; 20(6):1888-92. PubMed ID: 15575729
[TBL] [Abstract][Full Text] [Related]
11. Peptide mapping for detecting variants in protein products.
Garnick RL
Dev Biol Stand; 1992; 76():117-30. PubMed ID: 1478332
[TBL] [Abstract][Full Text] [Related]
12. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
13. Control of recombinant DNA produced pharmaceuticals by a combination of process validation and final product specifications.
Jones AJ; O'Connor JV
Dev Biol Stand; 1985; 59():175-80. PubMed ID: 4007276
[TBL] [Abstract][Full Text] [Related]
14. Purified protein products of rDNA technology expressed in animal cell culture.
Lubiniecki AS; Lupker JH
Biologicals; 1994 Jun; 22(2):161-9. PubMed ID: 7522477
[TBL] [Abstract][Full Text] [Related]
15. Process development for a recombinant Chinese hamster ovary (CHO) cell line utilizing a metal induced and amplified metallothionein expression system.
Huang EP; Marquis CP; Gray PP
Biotechnol Bioeng; 2004 Nov; 88(4):437-50. PubMed ID: 15459913
[TBL] [Abstract][Full Text] [Related]
16. Meeting the regulatory requirements for pharmaceutical production of recombinant DNA derived products.
Werner RG; Langlouis-Gau H
Arzneimittelforschung; 1989 Jan; 39(1):108-11. PubMed ID: 2719737
[TBL] [Abstract][Full Text] [Related]
17. Ensuring the consistency of rDNA-derived biologicals: the contribution of gene sequencing.
Griffiths E
Dev Biol Stand; 1994; 83():179-82. PubMed ID: 7883093
[TBL] [Abstract][Full Text] [Related]
18. Effects of ammonia and glucosamine on the heterogeneity of erythropoietin glycoforms.
Yang M; Butler M
Biotechnol Prog; 2002; 18(1):129-38. PubMed ID: 11822911
[TBL] [Abstract][Full Text] [Related]
19. Genetic and phenotypic markers and their relationship to product quality and consistency.
Adamson SR; Charlebois TS
Dev Biol Stand; 1994; 83():31-44. PubMed ID: 7883098
[TBL] [Abstract][Full Text] [Related]
20. Glycosylation variant analysis of recombinant human tissue plasminogen activator produced in urea-cycle-enzyme-expressing Chinese hamster ovary (CHO) cell line.
Kim HJ; Kim HJ
J Biosci Bioeng; 2006 Nov; 102(5):447-51. PubMed ID: 17189173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
